(Q35918796)

11 August 2017

A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects (English)

1 reference

11 August 2017

Moorhouse JA

1

1 reference

PMCID

1936014

11 August 2017

language of work or name

English

0 references

publication date

1 March 1967

1 reference

Canadian Medical Association Journal

11 August 2017

1 reference

11 August 2017

96

1 reference

11 August 2017

9

1 reference

11 August 2017

536-539

1 reference

CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS

11 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1936014

CLINICAL STUDY OF TOLAZAMIDE: A NEW ANTIDIABETIC SULFONYLUREA

27 July 2018

1 reference

12 December 2020

Determination of cholesterol with special reference to the use of p-toluene-sulfonic acid

1 reference

12 December 2020

TOLAZAMIDE (TOLANASE) -- A NEW SULPHONYLUREA

1 reference

12 December 2020

EVALUATION OF TOLAZAMIDE IN THE TREATMENT OF DIABETES MELLITUS

1 reference

12 December 2020

CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE)

1 reference

12 December 2020

Clinical evaluation of a new hypoglycemic sulfonylurea, tolazamide. A preliminary report on its chlorinated analogue, azepinamide

1 reference

12 December 2020

[1st clinical experience with a new oral hypoglycemic agent: tolazamide, 1-(hexahydro-1-azepinyl)-3-p-tolysulfonylurea]

1 reference

12 December 2020

A new high potency antidiabetic sulfonylurea [N-(1-hexahydro-1-azepinyl)-N'-p-tolyl-sulfonylurea]

1 reference

12 December 2020

The physical properties of chlorpropamide and its determination in human serum

1 reference

12 December 2020

Micromethod for the direct determination of serum triglycerides

1 reference

12 December 2020

Identifiers

PMCID

1936014

1 reference

11 August 2017

1 reference

PMCID

1936014